-
Aveo intros oral renal cell carcinoma treatment Fotivda
The medication is an oral, next generation vascular endothelial growth factor tyrosine kinase inhibitor. -
McKesson augments integrated pharmacy services for specialty clinics
McKesson’s health system clients will be offered VHRxS’ full suite of specialty pharmacy consulting services.